Genesis Healthcare, Inc.
GENN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $54 | $176 | $119 | $72 |
| - Cash | $212 | $12 | $21 | $55 |
| + Debt | $3,810 | $4,478 | $4,911 | $5,037 |
| Enterprise Value | $3,652 | $4,642 | $5,009 | $5,054 |
| Revenue | $3,906 | $4,566 | $4,977 | $5,374 |
| % Growth | -14.4% | -8.3% | -7.4% | – |
| Gross Profit | $1,650 | $2,081 | $2,190 | $2,337 |
| % Margin | 42.2% | 45.6% | 44% | 43.5% |
| EBITDA | $136 | $313 | $310 | -$214 |
| % Margin | 3.5% | 6.9% | 6.2% | -4% |
| Net Income | -$59 | $15 | -$235 | -$579 |
| % Margin | -1.5% | 0.3% | -4.7% | -10.8% |
| EPS Diluted | -0.53 | 0.1 | -2.33 | -6.15 |
| % Growth | -630% | 104.3% | 62.1% | – |
| Operating Cash Flow | $316 | -$7 | $19 | $120 |
| Capital Expenditures | -$56 | -$63 | -$51 | -$64 |
| Free Cash Flow | $260 | -$70 | -$33 | $56 |